StonvexLoading…
StonvexStonvexStonvexCore line items from IBP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $660.50M | $2.97B | $2.22B | $1.45B |
Operating Income | $57.60M | $386.40M | $277.60M | $170.80M |
Net Income | $34.80M | $265.40M | $188.80M | $114.40M |
EPS (Diluted) | $1.29 | $9.71 | $6.89 | $4.15 |
Total Assets | $2.23B | $2.07B | $2.05B | $2.02B |
Total Liabilities | $1.56B | $1.36B | $1.37B | $1.36B |
Cash & Equivalents | $474.30M | $321.90M | $333.30M | $305.20M |
Free Cash Flow OCF − CapEx | $85.70M | $300.80M | $251.50M | $146.70M |
Shares Outstanding | 26.94M | 26.98M | 27.13M | 27.33M |